Table 3. Characteristics of infections in EAS patients.
| Site | No. of patients | Number of patients with infection/ Pathogen |
|---|---|---|
| Respiratory | 5 | 1.Klebsiella oxytoca, Candida albicans |
| 1.Klebsiella pneumonia only | ||
| 3. na | ||
| Gastrointestinal tract | ||
| • oral cavity | 2 | 1.Cryptoccocus laurentii, |
| 1.na | ||
| • esophagus | 2 | 1.Candida albicans |
| 1. fungal infection | ||
| • small intestine | 1 | 1.Rotavirus |
| • liver-AVH | 1 | 1. Hepatitis B and C virus |
| Urinary tract | 6 | 1.Enterococcus faecalis, Streptoccocus viridans |
| 1.Enterococcus faecalis VRE | ||
| 2.Escherichia coli | ||
| 1.Enterococcus faecalis HLAR, Escherichia coli, Candida albicans | ||
| 1.na | ||
| Ear/nose | ||
| • otitis media | 1 | 1.na |
| Central venous catheter | 1 | 1.na |
| Cutaneous | ||
| acne | 1 | 1.na |
| Eye | ||
| • bilateral fungal endophthalmitis | 1 | 1.na |
| • bacterial conjunctivitis | 1 | 1.na |
| Postoperative wound | 3 | 1.Serratia marcescens, Morganella morgani |
| 1.Staphylococcus epidermidis | ||
| 1. Escherichia coli ESBL | ||
| Central nervous system | 1 | 1.na |
| Other | ||
| • coxitis fugax | 1 | 1.na |
| • suprahepatic abscess | 1 | 1.na |
| • abscess in the bursa omentalis | 1 | 1.Enterobacter cloacae ESBL |
| • sepsis | 2 | 1. Escherichia coli |
| 1.Klebasiella pneumoniae ESBL, Escherichia coli |
Abbreviations: na- not available; VRE—Vancomycin-resistant enterococci, HLAR—High-level aminoglycoside resistance; ESBL—Extended spectrum beta-lactamases; AVH—Acute viral hepatitis